|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0029925,
umls-concept:C0033325,
umls-concept:C0085862,
umls-concept:C0205179,
umls-concept:C0543467,
umls-concept:C0806909,
umls-concept:C0920317,
umls-concept:C1299583,
umls-concept:C1521761,
umls-concept:C1549571,
umls-concept:C1608386
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1992-3-20
|
|
pubmed:abstractText |
If maximum cytoreductive surgery benefits the survival of women with advanced ovarian cancer, the median survival time of groups of such women will improve as the proportion of women undergoing maximum cytoreductive surgery is increased.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
166
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
504-11
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?
|
|
pubmed:affiliation |
Institute of Obstetrics and Gynaecology, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.
|
|
pubmed:publicationType |
Journal Article,
Meta-Analysis
|
